Shenzhen Neptunus Bioengineering Co., Ltd.

¥1.26As of Sun 8 Nov 2026, 12:00 UTC
SZSE:000078Healthcare
Country China
PE (Fwd) •••
TSR 10Y CAGR (15.34%)
Div yield —
ROE (43.85%)
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.10
PE TTM —
TSR TTM (50.00%)
Mkt cap ¥3.315B
ROIC (0.41%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥1.38
9.63%
(62.23%)
Hold 4|5|1|6|12
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.02
0.02
0.02
0.02
32.60%
35.20%
40.22%
31.93%
Revenue¥M
164.5
173.4
177.2
179.9
2.97%
10.96%
7.98%
6.80%
Peers (US$497.0M)
Cap (US$)
PE
495.8M
—
495.8M
16.44x
499.0M
3.720x
Capital
TTM
5Y
10Y
Leveragex
0.431
0.038
0.045
EBIT/Intx
0.351
1.045
0.683
Own earn%
(9.16)
(138.03)
(122.89)
Sh yield%
29.60
32.56
36.31
Owners
Insiders/Inst%
7.08
56.30
Short interest%
1.52
SBC / revenue%
3.10
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
14
Op margin range%
23–26
$1 testx
—
Incr. ROIC%
4